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Abstract 
Subcutaneous adipose tissue (scAT) in human obesity undergoes severe alteration such as fibrosis which is related to metabolic 
alterations and to less efficiency in losing weight after bariatric surgery. There is currently no non-invasive tool to assess fibrosis 
in scAT. Vibration Controlled Transient Elastography (VCTE) using FibroScan® is widely used to assess liver fibrosis in clinical 
practice. A novel device named AdipoScan™ which is based on VCTE has been developed by Echosens (Paris) so as to assess 
scAT. The objective of this study is to show the first AdipoScan clinical results. AdipoScan™ was assessed in vivo on 73 
morbidly obese patients candidate for bariatric surgery who were enrolled in the Pitié Salpêtrière hospital. scAT shear wave 
speed measured by AdipoScan™ is significantly associated with scAT fibrosis, gender, hypertension status, total body fat mass 
assessed by DXA, hypertension status, glycemic, lipid, hepatic parameters and adiponectin. Results suggest that scAT evaluation 
before bariatric surgery can be useful in clinical practice since it is related to scAT fibrosis -who plays in role in weight loss 
resistance after bariatric surgery- and to obesity induced co-morbidities such as diabetes, hypertension liver dysfunction. 
© 2015 The Authors. Published by Elsevier B.V. 
Peer-review under responsibility of the Scientific Committee of 2015 ICU Metz. 
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1. Introduction 
Subcutaneous adipose tissue (scAT) in human obesity undergoes severe alteration such as fibrosis. It has been 
shown that this fibrosis is related to metabolic alterations and to less efficiency in losing weight after bariatric 
surgery (Divoux et al. 2010). There is currently no non-invasive tool to assess subcutaneous adipose tissue (scAT). 
Vibration Controlled Transient Elastography (VCTE™) using FibroScan® (Sandrin et al. 2003) is widely used to 
assess liver fibrosis in clinical practice. A novel device named AdipoScan which is based on VCTE has been 
developed by Echosens so as to assess scAT stiffness.  
The objective of this work is to describe briefly the new device AdipoScan and to show the clinical relevance of 
AdipoScan on morbidly obese patients candidates for bariatric surgery.  
2. Material and methods 
2.1. The AdipoScan™  device 
Transient elastography is the elastography principle used in the Fibroscan® (Sandrin et al. 2003) which is a 
device widely used to assess liver stiffness which is related to liver fibrosis (Bonder and Afdhal 2014). In transient 
elastography, the probe is constituted of an electromechanical vibrator for a transient shear wave generation on the 
axis of which a single element transducer is mounted. Low frequency vibrations (50 Hz for the Fibroscan®) are 
transmitted from the vibrator to the tissues via the transducer, thereby inducing a longitudinally polarized shear 
wave on the axis of the transducer that propagates through the tissue (Sandrin et al. 2002). In the meantime, ultrafast 
pulse-echo ultrasound acquisitions (pulse repetition frequency of 6000 Hz) allow the propagation of the shear wave 
to be followed. Shear wave speed (SWS) can be measured from displacements induced by shear wave propagation 
on what is called an elastogram image which represents the strains induced in the liver as a function of time and 
depth. 
AdipoScan™ was developed by Echosens company (Paris, France) using the same principle but adapted for the 
evaluation of scAT stiffness. Specifically: 
1. A new probe was developed (cf. Fig. 1). The probe is made up of a flat electromechanical transducer associated 
to a flat piezoelectric transducer with a 9 mm diameter and a 3.5 MHz center frequency. The designed probe fulfill 
the two main constraints i) to be light enough to minimize the initial static force to avoid compressing the tissues 
and modifying the viscoelastic properties of the scAT, ii) also to be small enough to be fixed on the patient skin on 
its own, without requiring the operator to hand hold the probe,  
2. The center frequency of the mechanical vibration was set at 70 Hz which is suitable for the evaluation of scAT in 
morbidly obese patients, 
3. SWS was assessed using a novel algorithm developed by Audière et al. (Audiere et al. 2014) which is 
particularly well adapted to scAT SWS evaluation. In this approach, SWS is derived from the maximum likelihood 
estimate of the comparison between the measured displacements and the estimated displacement provided by the 
Green's functions, 
4. The measurement zone was optimized. Measurements are performed on the right side of the patients belly at a 
few centimeter from it (cf. Fig. 1). The probe is embedded in a shell made up of a hard part maintaining the 
electromechanical vibrator and of three soft strips which allow the probe to be adapted to the patient’s morphology 
and to maintain the system by using sticking plaster as shown in Fig. 1. 
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Fig. 1. AdipoScan™ probe and area of scAT SWS measurement. 
2.2. AdipoScan reproducibility evaluation 
Reproducibility was evaluated on two tissue elasticity mimicking phantoms (reference elasticity 3kPa and 6 kPa ) 
manufactured by CIRS (Norfolk, VZ, USA. 10 consecutive measurements with and 10 without repositioning were 
performed. Reproducibility was also assessed in vivo on 41 volunteers (66% females, mean age = 46±12y, BMI 
ranging from 24 up to 59 kg/m2). 2 consecutive measurements with and 2 without repositioning were performed. All 
measurements were performed by a single trained operator. Reproducibility was assessed in terms of coefficient of 
variation. 
2.3. Study population 
73 morbidly obese subjects candidate to bariatric surgery were enrolled one month before surgery at the nutrition 
department of the Pitié Salpêtrière hospital (Paris, France). Patients gave their informed consent to participate into 
the study. The protocol was performed in accordance with Helsinki Declaration.  
All patients underwent AdipoScan evaluation using the same procedure performed by the same experience 
operator. Briefly, the AdipoScan™ probe was put on the patient’s right zone of the abdomen, at the distance of 
around 5 cm from the umbilic cf. Fig. 1. The final scAT shear wave speed corresponded to the median of at least 10 
valid individual measurements. 
Bioclinical parameters were collected including: age, gender, BMI, HbA1C, fasting glycemia, fasting insulin, 
triglycerides, total cholesterol, HDL cholesterol, apolipoprotein A1, apolipoprotein B, gamma glutamyl 
transpeptidase (γGT), creatinin, uricemia, CRP, orosomucoid, adiponectin, leptin and IL6. 
In 67 patients, body composition was assessed in 67 patients by whole body fan-beam DXA scanning (Hologic 
Discovery W, software v12.6, 2; Hologic, Bedford, MA) as described in (Abdennour et al. 2014). 
In 57 patients liver stiffness was assessed one month before surgery using Fibroscan® and its XL probe dedicated 
to obese and overweight patients as in (Naveau et al. 2014). If needed due to a large subcutaneous fat thickness, data 
were reprocessed between 40 and 60 mm. 
During surgery, subcutaneous white adipose tissue (scWAT) and liver biopsies were collected for 32 and 57 
patients respectively. Both scAT and liver biopsy specimen were fixed in formalin and embedded in paraffin and 
stained with picrosirius red. Liver biopsies were staged by single liver pathologist according the Kleiner score. On 
scAT biopsy specimen, the percentage of total and pericellular fibrosis was assessed as described in (Abdennour et 
al. 2014), together with adipocytes diameter. 
2.3.1. Statistical analyses 
The univariate relationship between scWAT stiffness and bioclinical parameters was assess using either Pearson 
(r), Spearman (ρ) or Kendall (τ) correlation coefficient or Wilcoxon signed-rank test.  
Due to the missing data for bioclinical parameter, the number of patients (N) with each given information will be 
indicated. 
 Magali Sasso et al. /  Physics Procedia  70 ( 2015 )  1264 – 1268 1267
Multivariate analyses were performed using multivariate linear regression to investigate the relationship between 
scWAT and bioclinical parameters. Due to its skewed distribution, scWAT was Box-Cox transformed so as to 
become gaussian. A backward procedure, based on the minimization of the Akaike criterion selected independent 
features significantly associated with scWAT stiffness.  
All statistical analysis were performed using the R software (R Core Team 2013). Statistical results associated 
with a p-value smaller than 0.05 were considered significant. 
3.      Results 
3.1. Reproducibility 
Reproducibility results in terms of coefficient of variation (CV%) are summarized in Table 1. 
Table 1. Reproducibility results 
 On tissue mimicking phantom in vivo 
 3 kPa 6 kPa  
Without repositioning 0% 0% 7% 
With repositioning  1.3% 1.4% 14% 
3.2. AdipoScan performance in vivo 
73 patients were enrolled into the study. 63 (86.3%) were female, their mean age was 44.3±10.4 years. Their 
BMI ranged from 35 up to 71 kg/m2 with a median value of 45 kg/m2 an interquartile range of 7 kg/m2. 
AdipoScan™ was successfully performed on all patients. scAT SWS ranged from 0.50 up to 2.52 m/s with a 
median value of 0.80 m/s and an interquartile range of 0.36 m/s. 
scAT SWS was significantly associated with the parameters summarized in Table 2. scAT SWS is independent of 
age, BMI, adipocytes diameter, apolipoprotein B, creatinin, uricemia, CRP, orosomucoid, leptin and IL6. 
Table 2. Parameters associated with scAT SWS in univariate analysis 
 Characteristics Association degree N 
 Gender p=0.04 73 
 Hypertention status p=0.02 73 
Body composition % total body lean mass r=0.41, p<10-3 67 
 % total body fat mass r=0.40, p<10-3 67 
Glycemic parameters Fasting glycemia r=0.33, p=0.005 71 
 HbA1C r=0.30, p=0.01 72 
 Fasting insulin r=0.25, p=0.03 73 
Lipid parameters Triglycerides ρ=0.25, p=0.05 67 
 Cholesterol r=-0.24, p=0.05 67 
 HDL cholesterol ρ=-0.26, p=0.04 67 
 Apolipoprotein A1 ρ=-0.33, p=0.009 63 
Adipokines Adiponectin r=-0.26, p=0.03 67 
Hepatic parameters Liver stiffness r=0.41, p=0.002 57 
 Liver fibrosis τ=0.27, p=0.01 53 
 γGT r=0.26, p=0.03 71 
scAT fibrosis scAT total fibrosis ρ=0.51, p=0.003 32 
 scAT pericellular fibrosis ρ=0.38, p=0.03 32 
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In multivariate analysis, scAT SWS is associated to the parameters summarized in Table 3. Please note the due 
the missing data, 2 different models were constructed one including liver fibrosis and one including scAT fibrosis 
since only 14 patients had both parameters assessed simultaneously.  
Table 3. Multivariate association with scAT SWS 
 Parameters included Association degree N 
Model 1 Gender, hypertension status, total body fat mass, 
HbA1C, apolipoprotein A1, adiponectin,  
liver stiffness, liver fibrosis 
Adiponectin, p=0.01 
Total body fat mass, p=0.01 
Liver fibrosis, p=0.002 
28 
Model 2 Gender, hypertension status, total body fat mass, 
HbA1C, apolipoprotein A1, adiponectin,  
scAT total fibrosis, scAT pericellular fibrosis 
Hypertension status, p=0.01 
Total body fatt mass, p=0.01 
scAT total fibrosis, p=0.03 
23 
4. Discussion 
In the present study, the feasibility of scAT SWS measurements in vivo was shown using a new device 
(AdipoScan™) specifically developed to assess scAT.  
Reproducibility of the device was shown to be good on tissue mimicking phantom but only fair in vivo. This is 
due to the complex and heterogeneous structure of scAT. Results are comparable with results found by other 
elastography techniques in complex medium such as in interveterbral discs stiffness evaluation (Vergari et al. 2014). 
scAT SWS was shown to be related to many bioclinical parameters in univariate analysis: scAT total and 
pericellular fibrosis but also to obesity induced comorbidities such as metabolism diabetic status, hypertension, lipid 
and liver dysfunctions.  
Results suggest that scAT evaluation before bariatric surgery can be useful in clinical practice. 
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